SCHEMBL2220683

SCHEMBL2220683

OCCc1ccc(N=Nc2cc(CCO)ccc2O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
ALOX5 P09917 1/20 0.53
GAA P10253 1/20 0.53
BACE1 P56817 1/20 0.53
CA2 P00918 2/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
CASP3 P42574 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
FTO Q9C0B1 1/20 0.44
MAPK1 P28482 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
NQO2 P16083 1/20 0.41
EGFR P00533 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
THRB P10828 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2220680 1.00 MAPT (0.53) MAPTKDM4EALDH1A1ALOX5GAA
SCHEMBL2221650 0.87 FTO (0.62) MAPTKDM4EALDH1A1ALOX5GAA
SCHEMBL2221644 0.87 FTO (0.62) MAPTKDM4EALDH1A1ALOX5GAA
SCHEMBL20574225 0.81 CA2 (0.56) MAPTKDM4EALDH1A1ALOX5GAA
SCHEMBL20574224 0.81 CA2 (0.56) MAPTKDM4EALDH1A1ALOX5GAA
SCHEMBL3194533 0.79 NQO2 (0.46) MAPTKDM4EALDH1A1GAACA2
SCHEMBL21650599 0.78 KMT2A (0.53) MAPTKDM4EALDH1A1ALOX5GAA
SCHEMBL12374390 0.74 MEN1 (0.70) MAPTALDH1A1CA2MAPK1EGFR
SCHEMBL3870420 0.74 TDP1 (0.62) MAPTKDM4EALDH1A1CA2L3MBTL1
SCHEMBL21786993 0.73 CA1 (0.46) MAPTKDM4EALDH1A1GAABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2526153-B1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2014-04-30 EP disclosed
CN-102712815-B Visible light absorbers for ophthalmic lens materials NOVARTIS AG 2013-12-25 CN disclosed
US-8329775-B2 Visible light absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-12-11 US disclosed
CN-102712815-A Visible light absorbers for ophthalmic lens materials NOVARTIS AG 2012-10-03 CN disclosed
US-20110178202-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-07-21 US disclosed
WO-2011088449-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178202-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS CRY1, CRY2, CRYAA MAPT 557/4885KDM4E 1154/4885ALDH1A1 624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.